NASDAQ:JAGX Jaguar Animal Health (JAGX) Stock Price, News & Analysis $3.70 -0.22 (-5.61%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$3.76 +0.06 (+1.62%) As of 06:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About Jaguar Animal Health Stock (NASDAQ:JAGX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jaguar Animal Health alerts:Sign Up Key Stats Today's Range$3.61▼$4.1250-Day Range$2.82▼$20.6752-Week Range$2.53▼$241.50Volume39,444 shsAverage Volume96,990 shsMarket Capitalization$1.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jaguar Animal Health, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the gastrointestinal health of food-producing animals, with an emphasis on swine and poultry. The company’s research and development efforts target common enteric disorders such as post-weaning diarrhea in pigs and clostridial overgrowth in broiler chickens, aiming to provide effective alternatives to traditional antibiotic treatments. Jaguar Animal Health was formed in early 2019 through the acquisition of the animal health business of Aratana Therapeutics by Actinium Animal Health, followed by a corporate rebranding. The company is headquartered in East Windsor, New Jersey, and maintains a streamlined development organization designed to advance lead candidates from proof-of-concept through regulatory approvals and commercial launch. Among Jaguar’s key offerings is a proprietary probiotic formulation intended to reduce the incidence and severity of post-weaning diarrhea in piglets, which has received regulatory clearance in select markets. In parallel, the company is progressing a complementary feed-additive candidate for controlling necrotic enteritis in broiler chickens. Jaguar leverages in-house expertise in microbial therapeutics to optimize dosing regimens and demonstrate consistent performance under commercial farming conditions. To date, Jaguar Animal Health serves customers primarily in Latin America through strategic distribution partnerships, while preparing for broader market entry in North America. The company’s leadership team brings experience in veterinary development, regulatory affairs, and commercial operations, positioning Jaguar to address growing global demand for effective, antibiotic-reducing solutions in livestock production.AI Generated. May Contain Errors. Read More Jaguar Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreJAGX MarketRank™: Jaguar Animal Health scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingJaguar Animal Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageJaguar Animal Health has only been the subject of 1 research reports in the past 90 days.Read more about Jaguar Animal Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted29.54% of the float of Jaguar Animal Health has been sold short.Short Interest Ratio / Days to CoverJaguar Animal Health has a short interest ratio ("days to cover") of 5.45.Change versus previous monthShort interest in Jaguar Animal Health has recently decreased by 82.07%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJaguar Animal Health does not currently pay a dividend.Dividend GrowthJaguar Animal Health does not have a long track record of dividend growth. News and Social Media3.2 / 5News SentimentN/A News SentimentJaguar Animal Health has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Jaguar Animal Health this week, compared to 1 article on an average week.Search Interest3 people have searched for JAGX on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Jaguar Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Jaguar Animal Health insiders have not sold or bought any company stock.Percentage Held by Insiders2.10% of the stock of Jaguar Animal Health is held by insiders.Percentage Held by Institutions12.04% of the stock of Jaguar Animal Health is held by institutions.Read more about Jaguar Animal Health's insider trading history. Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JAGX Stock News HeadlinesJaguar Animal Health Granted Short Nasdaq Compliance ExtensionMay 16 at 4:41 AM | theglobeandmail.comJaguar Animal Health (NASDAQ:JAGX) Upgraded to "Sell" at Wall Street ZenMay 10, 2026 | americanbankingnews.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 19 at 1:00 AM | Brownstone Research (Ad)Jaguar Health, Inc.: Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea in DogsApril 30, 2026 | finanznachrichten.deJaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for ...April 24, 2026 | usatoday.comJaguar Health, Inc. (JAGX) Q4 2025 Earnings Call Prepared Remarks TranscriptApril 10, 2026 | seekingalpha.comJaguar Health Inc.April 4, 2026 | barrons.comJaguar Health Delays Annual Form 10-K FilingApril 4, 2026 | theglobeandmail.comSee More Headlines JAGX Stock Analysis - Frequently Asked Questions How have JAGX shares performed this year? Jaguar Animal Health's stock was trading at $32.5920 at the beginning of the year. Since then, JAGX shares have decreased by 88.6% and is now trading at $3.70. How were Jaguar Animal Health's earnings last quarter? Jaguar Animal Health, Inc. (NASDAQ:JAGX) announced its quarterly earnings results on Friday, November, 14th. The biotechnology company reported ($219.80) earnings per share for the quarter, missing analysts' consensus estimates of ($177.80) by $42.00. The biotechnology company earned $3.08 million during the quarter, compared to the consensus estimate of $3.73 million. Jaguar Animal Health had a negative net margin of 464.20% and a negative trailing twelve-month return on equity of 1,194.94%. Read the conference call transcript. When did Jaguar Animal Health's stock split? Jaguar Animal Health shares reverse split on Thursday, May 23rd 2024.The 1-60 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Jaguar Animal Health IPO? Jaguar Animal Health (JAGX) raised $23 million in an IPO on Wednesday, May 13th 2015. The company issued 2,860,000 shares at a price of $7.00-$9.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. How do I buy shares of Jaguar Animal Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Jaguar Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Jaguar Animal Health investors own include CrowdStrike (CRWD), NVIDIA (NVDA), Meta Platforms (META), Digital Turbine (APPS) and Advanced Micro Devices (AMD). Company Calendar Last Earnings11/14/2025Today5/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 JAGX's financial health is in the Yellow zone, according to TradeSmith. JAGX has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:JAGX CIK1585608 Webwww.jaguaranimalhealth.com Phone(415) 371-8300FaxN/AEmployees50Year Founded2013Profitability EPS (Trailing Twelve Months)($1,162.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.43 million Net Margins-464.20% Pretax Margin-469.09% Return on Equity-1,194.94% Return on Assets-114.26% Debt Debt-to-Equity Ratio4.08 Current Ratio0.50 Quick Ratio0.29 Sales & Book Value Annual Sales$11.51 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value($106.12) per share Price / Book-0.03Miscellaneous Outstanding Shares370,000Free Float364,000Market Cap$1.37 million OptionableNo Data Beta0.01 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:JAGX) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Animal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
